AnalystsEdwin ZhangEdwin Zhang's Stock Forecasts
AnalystsEdwin Zhang
Sectors:
Industries:
Analyst Ranking
Top 35%
#1714 out of 4872 analysts
Average Return
+6.34%
Win Rate
40%4 out of 10
Risk vs Reward
Poor
Good
Edwin Zhang's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Calliditas Therapeutics AbCALT | +134.47% | $17.06 | $40.00 | 2023-10-16 - 2024-09-20 | Buy |
Calliditas Therapeutics AbCALT | +131.71% | $17.44 | $40.41 | 2023-08-21 - 2024-08-20 | Buy |
Calliditas Therapeutics AbCALT | +114.56% | $18.20 | $39.05 | 2023-06-20 - 2024-06-18 | Buy |
Enliven Therapeutics IncELVN | +26.33% | $13.52 | $17.08 | 2021-11-30 - 2022-11-29 | Buy |
Edwin Zhang Analyst Color
Get additional color on Edwin Zhang's coverage of popular stocks
Edwin Zhang's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Calliditas Therapeutics AbCALT | 4 | Buy | $50.00 | N/A | Reiterates | 2 years ago |
Onkure Therapeutics IncOKUR | 1 | Buy | $280.00 | N/A | Initiates Coverage On | 3 years ago |
Enliven Therapeutics IncELVN | 1 | Buy | $10.00 | N/A | Initiates Coverage On | 3 years ago |
Ultragenyx Pharmaceutical IncRARE | 1 | Buy | $106.00 | N/A | Initiates Coverage On | 4 years ago |
Logicbio Therapeutics IncLOGC2 | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 4 years ago |
Fibrogen IncFGEN | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Liminal Biosciences IncLMNL | 1 | Buy | $110.00 | N/A | Initiates Coverage On | 4 years ago |
Aldeyra Therapeutics IncALDX | 1 | Buy | $26.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.